Termination of Information Rights and Observer Rights. The covenants set forth in Subsections 3.1, 3.2 and 3.3 shall terminate and be of no further force or effect (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, as such term is defined in the Restated Certificate, in which the consideration received by the Investors is in the form of cash and/or marketable securities, whichever event occurs first.
Appears in 3 contracts
Samples: Investors’ Rights Agreement, Investors’ Rights Agreement (Rhythm Pharmaceuticals, Inc.), Investors’ Rights Agreement (Rhythm Pharmaceuticals, Inc.)
Termination of Information Rights and Observer Rights. The covenants set forth in Subsections Section 3.1, 3.2 Section 3.2, Section 3.3 and 3.3 Section 3.4 shall terminate and be of no further force or effect (i) immediately before the consummation of the IPOInitial Offering, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, as such term is defined in the Restated Certificate, in which the consideration received by the Investors is in the form Company’s Certificate of cash and/or marketable securitiesIncorporation, whichever event occurs first.
Appears in 2 contracts
Samples: Investor Rights Agreement, Investor Rights Agreement (Pinterest, Inc.)
Termination of Information Rights and Observer Rights. The covenants set forth in Subsections Sections 3.1, 3.2 and 3.3 shall terminate and be of no further force or effect upon the earliest to occur of (i) immediately before before, but subject to, the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, as such term is defined in the Restated Certificate, in which the consideration received by the Investors is in the form of cash and/or marketable securities, whichever event occurs first.
Appears in 2 contracts
Samples: Investors’ Rights Agreement (Ayala Pharmaceuticals, Inc.), Investors’ Rights Agreement (Ayala Pharmaceuticals, Inc.)
Termination of Information Rights and Observer Rights. The covenants set forth in Subsections Section 3.1, Section 3.2 and Section 3.3 shall terminate and be of no further force or effect (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon the closing of a Deemed Liquidation Event, as such term is defined in the Restated Certificate, in which the consideration received by the Investors is in the form Certificate of cash and/or marketable securitiesIncorporation, whichever event occurs first.
Appears in 2 contracts
Samples: Investors’ Rights Agreement (ArriVent Biopharma, Inc.), Investors’ Rights Agreement (ArriVent Biopharma, Inc.)
Termination of Information Rights and Observer Rights. The covenants set forth in Subsections Subsection 3.1, Subsection 3.2 and Subsection 3.3 shall terminate and be of no further force or effect (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon the closing of a Deemed Liquidation Event, as such term is defined in the Restated Certificate, in which the consideration received by the Investors is in the form Certificate of cash and/or marketable securitiesIncorporation, whichever event occurs first.
Appears in 1 contract
Samples: Investors’ Rights Agreement (Candel Therapeutics, Inc.)
Termination of Information Rights and Observer Rights. The covenants set forth in Subsections Subsection 3.1, Subsection 3.2 and Subsection 3.3 shall terminate and be of no further force or effect (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, as such term is defined in the Restated Certificate, in which the consideration received by the Investors is in the form Certificate of cash and/or marketable securitiesIncorporation, whichever event occurs first.
Appears in 1 contract
Samples: Investors’ Rights Agreement (Werewolf Therapeutics, Inc.)
Termination of Information Rights and Observer Rights. The covenants set forth in Subsections Section 3.1, Section 3.2 and Section 3.3 shall terminate and be of no further force or effect (i) immediately before the consummation of the an IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, as such term is defined in the Restated Certificate, in which the consideration received by the Investors is in the form Company’s Certificate of cash and/or marketable securitiesIncorporation, whichever event occurs first.
Appears in 1 contract